-
Allgens Medical Technology’s BonGold Receives Marketing Approval from Malaysia’s MDA
•
Allgens Medical Technology Co., Ltd, a Beijing-based innovator in regenerative medicine materials and implantable devices listed on the Shanghai Stock Exchange (SHA: 688613), has secured marketing approval from the Medical Device Authority (MDA) of Malaysia for its flagship product, BonGold, an artificial bone repair material. BonGold is a biomimetic mineralized…
-
Allgens Medical Technology to Acquire German Dental Implant Maker HumanTech Dental for EUR 3.25 Million
•
Beijing-based Allgens Medical Technology Co., Ltd (SHA: 688613), specializing in regenerative medicine materials and implantable devices, has announced plans to acquire all outstanding shares of HumanTech Dental GmbH, a German dental implant manufacturer, for a consideration of EUR 3.25 million (USD 3.5 million). Established in 2017, HumanTech Dental has been…
